Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-12 5:35 pm Unchanged | 2026-06-06 | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.000% | 0 (Unchanged) | Filing History |
| 2026-05-18 7:31 pm Purchase | 2026-05-11 | 13G | ARTIVA BIOTHERAPEUTICS INC ARTV | VIKING GLOBAL INVESTORS LP | 2,604,166 5.400% | 2,604,166 (New Position) | Filing History |
| 2026-05-15 5:48 pm Unchanged | 2026-03-31 | 13G | GINKGO BIOWORKS HLDGS INC DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 7.100% | 0 (Unchanged) | Filing History |
| 2026-05-15 5:48 pm Sale | 2026-03-31 | 13G | CHEWY INC CHWY | VIKING GLOBAL INVESTORS LP | 0 0.000% | -13,536,645 (Position Closed) | Filing History |
| 2026-05-15 5:48 pm Sale | 2026-03-31 | 13G | RALLYBIO CORP COM RLYB | VIKING GLOBAL INVESTORS LP | 528,954 9.990% | -3,694,015 (-87.47%) | Filing History |
| 2026-05-15 5:48 pm Purchase | 2026-03-31 | 13G | FORTIVE CORP COM FTV | VIKING GLOBAL INVESTORS LP | 22,479,388 7.100% | 1,995,708 (+9.74%) | Filing History |
| 2026-05-15 5:48 pm Unchanged | 2026-03-31 | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.000% | 0 (Unchanged) | Filing History |
| 2026-05-15 5:48 pm Purchase | 2026-03-31 | 13G | TIC SOLUTIONS INC TIC | VIKING GLOBAL INVESTORS LP | 35,824,562 16.200% | 1,464,562 (+4.26%) | Filing History |
| 2026-05-15 5:48 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | VIKING GLOBAL INVESTORS LP | 8,264,607 7.800% | -464,738 (-5.32%) | Filing History |
| 2026-05-15 5:48 pm Purchase | 2026-03-31 | 13G | SIONNA THERAPEUTICS INC SION | VIKING GLOBAL INVESTORS LP | 3,195,181 7.100% | 242,427 (+8.21%) | Filing History |
| 2026-05-15 5:48 pm Unchanged | 2026-03-31 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 18.800% | 0 (Unchanged) | Filing History |
| 2026-05-15 5:48 pm Sale | 2026-03-31 | 13G | PHARVARIS N V REGISTERED PHVS | VIKING GLOBAL INVESTORS LP | 3,653,310 5.600% | -3,613 (-0.10%) | Filing History |
| 2026-05-15 5:48 pm Sale | 2026-03-31 | 13G | VERADERMICS INC MANE | VIKING GLOBAL INVESTORS LP | 1,690,555 4.500% | -460,938 (-21.42%) | Filing History |
| 2026-05-15 5:48 pm Unchanged | 2026-03-31 | 13G | PEPGEN INC PEPG | VIKING GLOBAL INVESTORS LP | 3,482,434 5.030% | 0 (Unchanged) | Filing History |
| 2026-05-15 5:48 pm Unchanged | 2026-03-31 | 13G | ORUKA THERAPEUTICS INC ORKA | VIKING GLOBAL INVESTORS LP | 2,666,690 5.300% | 0 (Unchanged) | Filing History |
| 2026-05-15 5:48 pm Purchase | 2026-03-31 | 13G | INHIBRX BIOSCIENCES INC INBX | VIKING GLOBAL INVESTORS LP | 1,461,633 9.990% | 7,025 (+0.48%) | Filing History |
| 2026-05-01 5:38 pm Purchase | 2026-04-24 | 13G | ALTIMMUNE INC ALT | VIKING GLOBAL INVESTORS LP | 13,400,000 6.700% | 13,400,000 (New Position) | Filing History |
| 2026-04-22 7:13 pm Purchase | 2026-04-15 | 13G | LENNOX INTL INC LII | VIKING GLOBAL INVESTORS LP | 1,815,350 5.200% | 1,815,350 (New Position) | Filing History |
| 2026-04-02 6:40 pm Sale | 2026-03-31 | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 11,842,434 6.100% | -1,183,933 (-9.09%) | Filing History |
| 2026-02-17 8:46 pm Sale | 2026-02-12 | 13D | BRIDGEBIO PHARMA INC BBIO | VIKING GLOBAL INVESTORS LP | 13,026,367 6.800% | -2,867,567 (-18.04%) | Filing History |